MET Fundamental Analysis - MET.EXTRA GROUP SPA

Fundamental Rating

We assign a fundamental rating of 4 out of 10 to MET. MET was compared to 47 industry peers in the Financial Services industry. No worries on liquidiy or solvency for MET as it has an excellent financial health rating, but there are worries on the profitability. MET is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

In the past year MET was profitable.

In the past year MET had a positive cash flow from operations.

MET had positive earnings in 4 of the past 5 years.

In multiple years MET reported negative operating cash flow during the last 5 years.

1.2 Ratios

With a decent Return On Assets value of 5.38%, MET is doing good in the industry, outperforming 72.34% of the companies in the same industry.

Looking at the Return On Equity, with a value of 6.94%, MET is in line with its industry, outperforming 57.45% of the companies in the same industry.

The Return On Invested Capital of MET (8.36%) is better than 70.21% of its industry peers.

Measured over the past 3 years, the Average Return On Invested Capital for MET is in line with the industry average of 9.94%.

		Industry Rank	Sector Rank
ROA	5.38%
ROE	6.94%
ROIC	8.36%

ROA(3y)6.31%

ROA(5y)2.56%

ROE(3y)9.8%

ROE(5y)1.51%

ROIC(3y)10.32%

ROIC(5y)N/A

1.3 Margins

MET has a Profit Margin (5.08%) which is in line with its industry peers.

With a Operating Margin value of 9.64%, MET perfoms like the industry average, outperforming 48.94% of the companies in the same industry.

MET has a Gross Margin of 17.44%. This is in the lower half of the industry: MET underperforms 63.83% of its industry peers.

In the last couple of years the Gross Margin of MET has declined.

		Industry Rank	Sector Rank
OM	9.64%
PM (TTM)	5.08%
GM	17.44%

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.46%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so MET is creating value.

The number of shares outstanding for MET remains at a similar level compared to 1 year ago.

Compared to 5 years ago, MET has less shares outstanding

The debt/assets ratio for MET has been reduced compared to a year ago.

2.2 Solvency

MET has an Altman-Z score of 1.63. This is a bad value and indicates that MET is not financially healthy and even has some risk of bankruptcy.

MET has a Altman-Z score of 1.63. This is comparable to the rest of the industry: MET outperforms 55.32% of its industry peers.

MET has a debt to FCF ratio of 1.02. This is a very positive value and a sign of high solvency as it would only need 1.02 years to pay back of all of its debts.

With an excellent Debt to FCF ratio value of 1.02, MET belongs to the best of the industry, outperforming 85.11% of the companies in the same industry.

MET has a Debt/Equity ratio of 0.07. This is a healthy value indicating a solid balance between debt and equity.

The Debt to Equity ratio of MET (0.07) is better than 78.72% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	1.02
Altman-Z	1.63

ROIC/WACC1.55

WACC5.4%

2.3 Liquidity

MET has a Current Ratio of 2.48. This indicates that MET is financially healthy and has no problem in meeting its short term obligations.

Looking at the Current ratio, with a value of 2.48, MET is in the better half of the industry, outperforming 78.72% of the companies in the same industry.

A Quick Ratio of 1.66 indicates that MET should not have too much problems paying its short term obligations.

MET has a better Quick ratio (1.66) than 72.34% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.48
Quick Ratio	1.66

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

MET shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -18.50%.

The Revenue for MET has decreased by -15.62% in the past year. This is quite bad

MET shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 126.36% yearly.

EPS 1Y (TTM)-18.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%2.33%

Revenue 1Y (TTM)-15.62%

Revenue growth 3Y297.58%

Revenue growth 5Y126.36%

Sales Q2Q%4.72%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 3.04 indicates a rather cheap valuation of MET.

Based on the Price/Earnings ratio, MET is valued cheaply inside the industry as 91.49% of the companies are valued more expensively.

MET is valuated cheaply when we compare the Price/Earnings ratio to 27.38, which is the current average of the S&P500 Index.

		Industry Rank	Sector Rank
PE	3.04
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MET indicates a rather cheap valuation: MET is cheaper than 100.00% of the companies listed in the same industry.

Based on the Price/Free Cash Flow ratio, MET is valued cheaper than 95.74% of the companies in the same industry.

		Industry Rank	Sector Rank
P/FCF	0.25
EV/EBITDA	0.26

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

MET does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

MET.EXTRA GROUP SPA

BIT:MET (9/10/2025, 7:00:00 PM)

1.46

-0.06 (-3.95%)

Chartmill FA Rating

GICS SectorFinancials

GICS IndustryGroupFinancial Services

GICS IndustryFinancial Services

Earnings (Last)N/A N/A

Earnings (Next)N/A N/A

Inst Owners1.3%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap846.80K

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	3.04
Fwd PE	N/A
P/S	0.02
P/FCF	0.25
P/OCF	0.18
P/B	0.03
P/tB	0.06
EV/EBITDA	0.26

EPS(TTM)0.48

EY32.88%

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)5.95

FCFY407.3%

OCF(TTM)8.04

OCFY551.02%

SpS68.51

BVpS50.2

TBVpS22.78

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	5.38%
ROE	6.94%
ROCE	12.12%
ROIC	8.36%
ROICexc	9.24%
ROICexgc	20.84%
OM	9.64%
PM (TTM)	5.08%
GM	17.44%
FCFM	8.68%

ROA(3y)6.31%

ROA(5y)2.56%

ROE(3y)9.8%

ROE(5y)1.51%

ROIC(3y)10.32%

ROIC(5y)N/A

ROICexc(3y)10.81%

ROICexc(5y)N/A

ROICexgc(3y)24.44%

ROICexgc(5y)N/A

ROCE(3y)14.96%

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-6.46%

GM growth 5YN/A

F-Score6

Asset Turnover1.06

Health

		Industry Rank	Sector Rank
Debt/Equity	0.07
Debt/FCF	1.02
Debt/EBITDA	0.37
Cap/Depr	93.9%
Cap/Sales	3.06%
Interest Coverage	250
Cash Conversion	91.03%
Profit Quality	170.74%
Current Ratio	2.48
Quick Ratio	1.66
Altman-Z	1.63

F-Score6

WACC5.4%

ROIC/WACC1.55

Cap/Depr(3y)150.57%

Cap/Depr(5y)N/A

Cap/Sales(3y)3.95%

Cap/Sales(5y)2.42%

Profit Quality(3y)203.21%

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-18.5%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%2.33%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-15.62%

Revenue growth 3Y297.58%

Revenue growth 5Y126.36%

Sales Q2Q%4.72%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y-15.81%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-65.99%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-63.83%

OCF growth 3YN/A

OCF growth 5YN/A

MET.EXTRA GROUP SPA (MET.MI) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens